| Andrographolide |
Influence on apoptotic and cell cycle protein activity |
Western Blot |
10.00 µM |
AsPC-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on apoptotic and cell cycle protein activity |
Western Blot |
25.00 µM |
AsPC-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on apoptotic and cell cycle protein activity |
Western Blot |
50.00 µM |
AsPC-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on apoptotic and cell cycle protein activity |
Western Blot |
10.00 µM |
Panc-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on apoptotic and cell cycle protein activity |
Western Blot |
25.00 µM |
Panc-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on apoptotic and cell cycle protein activity |
Western Blot |
50.00 µM |
Panc-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on apoptotic and cell cycle protein activity in presence of gemcitabine |
Western Blot |
10.00 µM |
AsPC-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on apoptotic and cell cycle protein activity in presence of gemcitabine |
Western Blot |
10.00 µM |
Panc-1 |
Homo sapiens |
|
|
|
| Andrographolide |
Influence on protein activity in presence of doxorubicin |
Western Blot |
15.00 µM |
MDA-MB-231 |
Homo sapiens |
|
|
|
